EGFR and neoplasm: Dysregulation of EGFR signaling has been shown to stimulate tumor cell proliferation, inhibit apoptosis, and promote angiogenesis and metastatic spread; and aberrations of the EGFR pathway are a common feature of HNSCC and are associated with worse prognosis [33].